Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5802271
[patent_doc_number] => 20020010190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'N-heterocyclic derivatives as NOS inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/814787
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15073
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010190.pdf
[firstpage_image] =>[orig_patent_app_number] => 09814787
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/814787 | N-heterocyclic derivatives as NOS inhibitors | Mar 21, 2001 | Issued |
Array
(
[id] => 5951912
[patent_doc_number] => 20020006923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Thrombin inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/815404
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16340
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20020006923.pdf
[firstpage_image] =>[orig_patent_app_number] => 09815404
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/815404 | Thrombin inhibitors | Mar 21, 2001 | Issued |
Array
(
[id] => 6034019
[patent_doc_number] => 20020019523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Substituted piperidines as melanocortin receptor agonists'
[patent_app_type] => new
[patent_app_number] => 09/812965
[patent_app_country] => US
[patent_app_date] => 2001-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35448
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019523.pdf
[firstpage_image] =>[orig_patent_app_number] => 09812965
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/812965 | Substituted piperidines as melanocortin receptor agonists | Mar 19, 2001 | Issued |
Array
(
[id] => 1517533
[patent_doc_number] => 06500811
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-31
[patent_title] => 'Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and use'
[patent_app_type] => B2
[patent_app_number] => 09/811698
[patent_app_country] => US
[patent_app_date] => 2001-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8144
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 2079
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500811.pdf
[firstpage_image] =>[orig_patent_app_number] => 09811698
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/811698 | Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and use | Mar 19, 2001 | Issued |
09/811779 | Substituted aryl and heteroaryl compounds as e-type prostaglandin antagonists | Mar 18, 2001 | Abandoned |
Array
(
[id] => 7631288
[patent_doc_number] => 06635644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-10-21
[patent_title] => 'Inhibitors of p38'
[patent_app_type] => B2
[patent_app_number] => 09/809921
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8928
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635644.pdf
[firstpage_image] =>[orig_patent_app_number] => 09809921
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/809921 | Inhibitors of p38 | Mar 15, 2001 | Issued |
Array
(
[id] => 6678948
[patent_doc_number] => 20030229089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Cyclic compounds'
[patent_app_type] => new
[patent_app_number] => 10/258545
[patent_app_country] => US
[patent_app_date] => 2002-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44528
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10258545
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/258545 | Pyrimidine compounds | Mar 14, 2001 | Issued |
Array
(
[id] => 773808
[patent_doc_number] => 07001905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => 'Substituted diarylamines as MEK inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/221522
[patent_app_country] => US
[patent_app_date] => 2001-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19393
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001905.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221522
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221522 | Substituted diarylamines as MEK inhibitors | Mar 11, 2001 | Issued |
Array
(
[id] => 6033466
[patent_doc_number] => 20020019383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation'
[patent_app_type] => new
[patent_app_number] => 09/798589
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12776
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019383.pdf
[firstpage_image] =>[orig_patent_app_number] => 09798589
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/798589 | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation | Mar 1, 2001 | Issued |
Array
(
[id] => 467750
[patent_doc_number] => 07235551
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-26
[patent_title] => '1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 10/220103
[patent_app_country] => US
[patent_app_date] => 2001-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 29603
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/235/07235551.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220103
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220103 | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases | Mar 1, 2001 | Issued |
Array
(
[id] => 1289545
[patent_doc_number] => 06632815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-10-14
[patent_title] => 'Inhibitors of factor Xa'
[patent_app_type] => B2
[patent_app_number] => 09/794214
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46592
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1517
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/632/06632815.pdf
[firstpage_image] =>[orig_patent_app_number] => 09794214
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/794214 | Inhibitors of factor Xa | Feb 27, 2001 | Issued |
Array
(
[id] => 1085800
[patent_doc_number] => 06831069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-14
[patent_title] => 'Pyrrolo2,3-dpyrimidine nucleoside analogs'
[patent_app_type] => B2
[patent_app_number] => 09/797549
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 31
[patent_no_of_words] => 19205
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/831/06831069.pdf
[firstpage_image] =>[orig_patent_app_number] => 09797549
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/797549 | Pyrrolo2,3-dpyrimidine nucleoside analogs | Feb 27, 2001 | Issued |
Array
(
[id] => 1467309
[patent_doc_number] => 06458798
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Bicyclic pyrimidine compounds and therapeutic use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/763728
[patent_app_country] => US
[patent_app_date] => 2001-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13433
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 342
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458798.pdf
[firstpage_image] =>[orig_patent_app_number] => 09763728
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/763728 | Bicyclic pyrimidine compounds and therapeutic use thereof | Feb 26, 2001 | Issued |
09/763705 | 2,4-DIAMINO PYRIMIDINE COMPOUNDS HAVING ANTI-CELL PROLIFERATIVE ACTIVITY | Feb 25, 2001 | Abandoned |
Array
(
[id] => 1289601
[patent_doc_number] => 06632820
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-14
[patent_title] => 'Pyrimidine compounds'
[patent_app_type] => B1
[patent_app_number] => 09/763681
[patent_app_country] => US
[patent_app_date] => 2001-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18967
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/632/06632820.pdf
[firstpage_image] =>[orig_patent_app_number] => 09763681
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/763681 | Pyrimidine compounds | Feb 25, 2001 | Issued |
Array
(
[id] => 1440621
[patent_doc_number] => 06495686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-12-17
[patent_title] => 'Pyrimido 4,5,bindolizine derivatives and aza analogues thereof; CRF1 specific ligands'
[patent_app_type] => B2
[patent_app_number] => 09/791370
[patent_app_country] => US
[patent_app_date] => 2001-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7307
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 349
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/495/06495686.pdf
[firstpage_image] =>[orig_patent_app_number] => 09791370
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/791370 | Pyrimido 4,5,bindolizine derivatives and aza analogues thereof; CRF1 specific ligands | Feb 22, 2001 | Issued |
Array
(
[id] => 1414504
[patent_doc_number] => 06525056
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-02-25
[patent_title] => 'Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders'
[patent_app_type] => B2
[patent_app_number] => 09/789673
[patent_app_country] => US
[patent_app_date] => 2001-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25601
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1847
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525056.pdf
[firstpage_image] =>[orig_patent_app_number] => 09789673
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/789673 | Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (CRH) antagonists, useful for treating cns and stress-related disorders | Feb 20, 2001 | Issued |
Array
(
[id] => 6097013
[patent_doc_number] => 20020052386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/785599
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20521
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20020052386.pdf
[firstpage_image] =>[orig_patent_app_number] => 09785599
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/785599 | Kinase inhibitors | Feb 15, 2001 | Abandoned |
Array
(
[id] => 6097013
[patent_doc_number] => 20020052386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-02
[patent_title] => 'Kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/785599
[patent_app_country] => US
[patent_app_date] => 2001-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20521
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20020052386.pdf
[firstpage_image] =>[orig_patent_app_number] => 09785599
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/785599 | Kinase inhibitors | Feb 15, 2001 | Abandoned |
Array
(
[id] => 6892281
[patent_doc_number] => 20010018443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-08-30
[patent_title] => 'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'
[patent_app_type] => new
[patent_app_number] => 09/782284
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21355
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20010018443.pdf
[firstpage_image] =>[orig_patent_app_number] => 09782284
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/782284 | Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds | Feb 13, 2001 | Issued |